Advances in Molecular DiagnosticsView this Special Issue
Research Article | Open Access
A Pentaplex PCR Assay for the Detection and Differentiation of Shigella Species
The magnitude of shigellosis in developing countries is largely unknown because an affordable detection method is not available. Current laboratory diagnosis of Shigella spp. is laborious and time consuming and has low sensitivity. Hence, in the present study, a molecular-based diagnostic assay which amplifies simultaneously four specific genes to identify invC for Shigella genus, rfc for S. flexneri, wbgZ for S. sonnei, and rfpB for S. dysenteriae, as well as one internal control (ompA) gene, was developed in a single reaction to detect and differentiate Shigella spp. Validation with 120 Shigella strains and 37 non-Shigella strains yielded 100% specificity. The sensitivity of the PCR was 100 pg of genomic DNA, 5.4 × 104 CFU/ml, or approximately 120 CFU per reaction mixture of bacteria. The sensitivity of the pentaplex PCR assay was further improved following preincubation of the stool samples in Gram-negative broth. A preliminary study with 30 diarrhoeal specimens resulted in no cross-reaction with other non-Shigella strains tested. We conclude that the developed pentaplex PCR assay is robust and can provide information about the four target genes that are essential for the identification of the Shigella genus and the three Shigella species responsible for the majority of shigellosis cases.
Shigellosis continues to be a major health problem in many parts of the world, particularly in underdeveloped and developing countries with poor sanitary systems and improper treatment of water supplies, and also among travelers from industrialized nations [1, 2]. Worldwide, mortality and morbidity due to shigellosis were found to be highest among young children 1 to 5 years of age and the elderly [3–5]. Three species of Shigella are responsible for the majority of shigellosis cases: S. flexneri, S. sonnei, and S. dysenteriae. Of these, S. sonnei is encountered mostly in industrialized countries and S. flexneri in developing countries; S. dysenteriae is the only epidemic and pandemic strain [2, 4, 6, 7]. The pathogenesis of shigellosis includes inflammation, ulceration, haemorrhage, tissue destruction, and fibrosis of the colonic mucosa, which result in abdominal pain and diarrhoea/dysentery; in some cases infertility and endometriosis also have been reported [8, 9]. Bacteraemia may occur in people with severe infections, particularly in malnourished children and AIDS patients . A more recent annual estimate of shigellosis throughout the world was estimated to be 90 million incidences and 108,000 deaths .
Shigella infection spreads by the faecal-oral route. Because of the low infectious dose (10 to 100 organisms), person-to-person transmission is likely the most common route of infection, as the bacteria can survive gastric acidity better than other enteric bacteria [10, 12]. However, transmission via contaminated water, food, overcrowded communities, food handlers, contaminated swimming pools, and flies also has been documented [8, 13, 14]. Recent increases in the number of cases of shigellosis in many parts of the world are attributed to the emergence of multiple-drug resistant strains. Early and accurate diagnosis of shigellosis coupled with prompt medical intervention is essential for reducing the morbidity and mortality caused by Shigella spp.
Shigella spp. are fragile organisms that are excreted in large numbers in the stool, but they die off quickly because stools are acidic . Thus, routine microbiological methods used to identify Shigella spp. from stool samples are relatively inefficient, time consuming, and labor intensive, and the diagnosis often remains obscure due to the presence of low numbers of causative organisms, competition from other commensal organisms, and inappropriate sample collection. If samples are collected after antibiotic therapy, growth of the organism may be impaired. Moreover, Dutta et al.  and Islam et al.  reported the sensitivity of the culture method to be 54% and 74%, respectively, compared to that of the conventional PCR technique. Recent molecular diagnostic techniques based on nucleic acids, such as PCR, have shown tremendous potential for identifying Shigella spp. and have been increasingly exploited.
To date, few studies have focused on the rapid diagnosis of shigellosis in underdeveloped and developing countries. However, PCR diagnostic tests have proven to be rapid and effective for the detection and identification to Shigella spp. [16–18]. In this study, we searched for genes unique to the Shigella serovars and used them to design a pentaplex PCR assay. Our assay differs from conventional multiplex PCRs, which often target the invasion plasmid H (ipaH) gene, O antigen synthesis genes, and the 16S rRNA gene for detection of Shigella spp. [18–20]; in those cases, the diagnosis is often based on sequence polymorphisms or differences rather than on the absence or presence of a gene. Those methods do not detect Shigella at the genus and species level simultaneously. The goal of the present study was to design a pentaplex PCR of Shigella spp. with an internal control for the detection of the genus Shigella and also for the clinically important Shigella spp., namely, S. flexneri, S. sonnei, and S. dysenteriae.
2.1. Bacterial Strains and Growth Conditions
A total of 120 Shigella strains of S. flexneri (), S. sonnei (), S. dysenteriae () and S. boydii (), were used in this study. Pure culture strains were isolated from patients admitted to Hospital Universiti Sains Malaysia (HUSM) from 2001 to 2009. Table 2 lists the Shigella spp. reference strains and other bacteria used in this study. Non-Shigella strains were used to determine the specificity and robustness of the assay. All the strains were biochemically and serologically confirmed and were stored at −80°C in 16% glycerol.
2.2. Isolation of Shigella Spp. from Clinical Specimens Using a Conventional Method
Stool specimens were inoculated on MacConkey (Oxoid Ltd., UK) and deoxycholate citrate agar (DCA) (Oxoid Ltd., UK) using a sterile inoculating loop. Stools were also enriched in selenite F broth (Oxoid Ltd., UK) and incubated overnight at °C. The next day, the enriched broth was subcultured on MacConkey agar and DCA and incubated overnight at °C. Colonies morphologically resembling Shigella spp. were further evaluated with biochemical tests using triple sugar iron (Oxoid Ltd., UK), urea agar slant (Oxoid Ltd., UK), methyl red (Oxoid Ltd., UK), Simmon’s citrate agar slant (Oxoid Ltd., UK), and sulphur indole motility medium (Oxoid Ltd., UK). Identities of colonies were serologically confirmed by slide agglutination with appropriate group-specific polyvalent antisera followed by type-specific monovalent antisera (Denka-Seiken, Tokyo, Japan). Nonserotypable isolates were further checked using an API 20E kit (BioMerieux, Marcy I’Etoile, France).
2.3. Primer Design for Pentaplex PCR Assay
The gene sequence for invC of the genus Shigella and gene sequences for rfc, wbgZ, and rfpB of S. flexneri, S. sonnei, and S. dysenteriae, respectively, were obtained from GenBank  for DNA sequence alignment and primer design. The ClustalW program in Vector NTI version 9.0 software (Invitrogen, Carlsbad, CA, USA) was used to align the DNA sequences. The conserved and non-conserved regions of the DNA sequence alignments were visualized using GeneDoc software .
Based on the conserved regions of the alignment, specific primer pairs for the genus Shigella were designed to amplify the invC gene. Specific primers for S. flexneri, S. sonnei, and S. dysenteriae were designed based on the non-conserved regions of rfc, wbgZ, and rfpB genes, respectively. The four primer pairs were designed in such a way that amplification efficiency was not hindered and amplicon sizes ranging from 211 to 875 bp could be differentiated by agarose gel electrophoresis (Figure 1). The homology of the designed primer sequences was analyzed using BLAST . A primer pair based on the ompA gene was designed (1319 bp) and used as an internal control. The primer (AIT BIOTECH, Singapore) sequences for the five genes and expected PCR product sizes are shown in Table 1.
bReference strains from American Type Culture Collection (ATCC), Reston, VA, USA.
cDepartment of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia.
dObtained from Institute for Medical Research, Malaysia.
“+” is positive; “–” is negative by pentaplex PCR.
2.4. Pentaplex PCR Assay
The pentaplex PCR assay was standardized using genomic DNA extracted from reference Shigella spp. A mixture of DNA from three strains (S. flexneri (SH052), S. sonnei (SH023), and S. dysenteriae (SD375)) that contained the four genes of interest was used as a positive control. DNase-free distilled water was used as a negative control. In addition, a plasmid containing the ompA gene (10 pg) was incorporated as an internal control template to rule out false negative results. An internal control (primer pair and template) was incorporated into every reaction mixture, including negative controls.
The colonies isolated from blood agar were inoculated into nutrient agar (Oxoid Ltd., UK) and incubated overnight at °C. Bacteria lysate was prepared by resuspending one bacterial colony in 30 μL of deionized water, boiling for 5 min, and centrifuging at 8000 ×g for 2 min. Two microliters of supernatant then were used as the DNA template in the pentaplex PCR assays.
The optimized primer concentration for each gene (0.4 pmol for ompA, rfc, and rfpB; 0.3 pmol for invC; and 0.2 pmol for wbgZ) was used in the pentaplex PCR. The other components used in the PCR were 200 μM dNTPs, 2.5 mM MgCl2, 1X PCR buffer, and 1 U Taq DNA polymerase (Promega, Madison, WI, USA). The PCR was performed using a Mastercycler Gradient (Eppendorf, Hamburg, Germany) with one cycle of initial denaturation at 94°C for 3 min, 30 cycles of denaturation at 94°C for 30 s, annealing for 30 s at 60°C, and extension at 72°C for 30 s, followed by an extra cycle of annealing at 60°C for 30 s and a final extension at 72°C for 3 min. The PCR products were analyzed by electrophoresis on 1.5% agarose gels (Promega) with 10 mg/mL ethidium bromide (Sigma, USA); they were run at 100 V for 60 min. PCR products were visualized under a UV transilluminator and photographed using an image analyzer (ChemiImager 5500; Alpha Innotech, San Leandro, CA, USA).
2.5. Evaluation of Pentaplex PCR Assay Results
Analytical specificity was evaluated using DNA lysate prepared from pure cultures of 120 Shigella strains, 10Gram-positive strains, and 27 Gram negative strains. The analytical sensitivity was evaluated using genomic DNA (1 μg to 10 pg) and also 108 to 102 CFU/mL obtained from Shigella strains. The diagnostic evaluation of the pentaplex PCR was conducted using 95 S. flexneri, 20 S. sonnei, 3 S. dysenteriae, and 2 S. boydii strains. The results were compared with those from the conventional culture method, which is considered to be the standard of detection .
2.6. Faecal Spiking and Sensitivity
The standardized pentaplex PCR assay designed to detect Shigella directly from stool was also tested using stool samples spiked with a known amount of Shigella based on slight modification of method described by Houng et al. . Stool samples (, children ≤ 5 years old) were collected from the Department of Medical Microbiology and Parasitology, HUSM, Malaysia, and were pretested for the presence of amplifiable Shigella DNA by pentaplex PCR and found to be negative. Five grams of stool were weighed and suspended in 45 mL of normal saline (NS) solution, which corresponds to a 10% mixture. The solution was vortexed for 2 min to obtain a homogenous mixture. Insoluble particulate matter was removed by low-speed centrifugation (1000 ×g) for 3 min, and the supernatant was transferred to a fresh tube. Meanwhile, an overnight culture of Shigella-specific strains was grown in nutrient broth (NB) (Oxoid Ltd., UK) under shaking condition (200 rpm). The bacterial count was estimated to be 108 CFU and 10-fold diluted with NS. Next, a 500 μL sample of each dilution of bacterial cells was mixed with 500 μL of the faecal suspension in a new tube. Tubes were vortexed, 1 mL of the mixture was transferred to 9 mL of GNB (Merck, Germany), and the mixture was preincubated at °C for up to 6 h without shaking. At time 0, 2, 4, and 6 h after incubation, 200 μL of mixture was placed in a 0.5 mL microcentrifuge tube and centrifuged at 8000 ×g for 3 min. The supernatant was removed, cells were washed using NS, and lysates were prepared by the boiling method. Two microliters of the lysate supernatant were used for pentaplex PCR evaluation.
2.7. Screening of Clinical Specimens
Stool samples were collected from patients suspected with acute gastroenteritis or dysentery from Department of Medical Microbiology and Parasitology, USM, Malaysia. Approximately 1 g of each faecal sample from 30 patients suspected of dysentery was transferred to 9 mL of GNB broth corresponding to 10% mixture and preincubated at 37°C ± 2°C for 4 h without shaking. Subsequently, 200 μL of the suspension was taken out and placed in 0.5 mL microcentrifuge tube and centrifuged at 8000 ×g for 3 min. The supernatant was discarded and cells were washed with 200 μL of 0.9% NS. Pellet was resuspended with 30 μL of PCR grade water and boiled for 5 min. Two microlitres of the supernatant containing DNA (lysate) were used for thermostabilized multiplex PCR evaluation. A pure culture of strain and a Shigella spiked faecal sample served as positive controls whilst a PCR reaction mixture without bacterial DNA template and an unspiked faecal sample from a healthy individual were incorporated as negative controls.
We developed a pentaplex PCR assay that simultaneously amplifies four specific genes and one internal control gene in a single reaction; this assay allows detection and differentiation of Shigella at the genus and species levels (Table 1). Based on the compatibility of the primers for different genes, the pentaplex PCR was standardized for the invC (genus Shigella), rfc (S. flexneri), wbgZ (S. sonnei), and rfpB (S. dysenteriae) genes. The fifth primer set (ompA) was used for amplification of the internal control to validate the reliability of the assay and to exclude false negative results. Figure 1 shows a representative gel that illustrates differentiation of Shigella by genus and species.
All of the primers were positive for the genes targeted by pentaplex PCR but negative for non-Shigella strains (Table 2). The optimum concentration of primer needed to amplify uniformly with approximately the same band intensity was 0.4 pmol for ompA, rfc, and rfpB; 0.3 pmol for invC; and 0.2 pmol for wbgZ. The pentaplex PCR gave the best results when 2.5 mM MgCl2, 200 μM dNTPs, and 1 U Taq polymerase were used. The optimal annealing temperature was 60°C.
The pentaplex PCR assay was evaluated for analytical specificity and sensitivity. At the DNA level sensitivity was 100 pg of DNA (Figure 2) and at the bacterial level it was 5.4 × 104 CFU/mL or approximately 120 CFU per reaction mixture of bacteria (Figure 3). The analytical specificity of the pentaplex PCR assay was evaluated using 120 clinical strains of Shigella spp. (95 S. flexneri, 20 S. sonnei, 3 S. dysenteriae, and 2 S. boydii), 10 Gram positive strains, and 27 Gram negative strains (Table 2).
Of the 120 Shigella strains tested, 116 were positive for invC. Of the 20 strains of S. sonnei, 16 were positive for wbgZ. The fact that four strains were wbgZ and invC negative suggests that the virulence plasmid might have been lost due to long storage time or subculturing . The rfc and rfpB primers showed 100% sensitivity in identifying their respective strains (Table 3).
The DNA sequencing results of the PCR amplicons for the four genes were aligned using Vector NTI version 9.0 software and then analyzed by BLAST. The results showed that all four PCR amplicons were specific to their respective genes and had 100% sequence identity with the existing GenBank sequences.
The effect of enrichment for Shigella count was investigated by spiking normal stool samples with known Shigella numbers and incubating the mixture in growth medium. The sample inoculated with 103 CFU/mL did not generate any amplicon at time zero (before incubation); however S. flexneri, S. sonnei, and S. dysenteriae produced clear amplicons after 4 h of incubation. This result illustrates that it is possible to detect Shigella spp. from samples containing low bacterial concentration by preincubating the samples in growth medium. A preliminary study on the efficacy of the multiplex PCR assay was evaluated using 30 faecal samples which were culturally confirmed negative for Shigella spp. No target genes were amplified in the multiplex PCR assay although both the positive and internal controls had amplifications.
Shigellosis is the most communicable of the bacterial diarrhoeas . This disease occurs as sporadic cases and occasional outbreaks of varying magnitude in developed countries and causes epidemics and endemic disease in developing countries. Because shigellosis is highly contagious, it is crucial to develop a rapid method for identifying the bacteria in order to limit and control outbreaks. Classical methods for determining the presence of bacteria in general are time consuming and labor intensive and have low sensitivity [16, 17, 25–27]. Hence, molecular methods, which offer speed, sensitivity, and specificity, have been developed to address this problem. However, some of these methods are relatively expensive and difficult to perform and require special equipment (e.g., a method combining immunocapture with PCR of bacteria for the detection of Shigella spp. , seminested PCR , PCR-nonradioactive labeling , PCR-RFLP , and PCR-ELISA ). On the other hand, DNA microarray analysis proved to be specific, sensitive, and reproducible, but its application as a diagnostic or epidemiological tool is difficult in view of the elevated cost, instruments and requires a skilled person to perform the test .
To overcome these drawbacks of existing techniques, we developed a pentaplex PCR assay and evaluated its ability to detect and identify three enteropathogenic bacteria species at the genus and species levels. Several previous studies described the development of Shigella multiplex PCR, but those assays did not discriminate between Shigella at the genus and species levels, nor did they differentiate Shigella from closely related pathogens such as Salmonella, Citrobacter, and enteroinvasive Escherichia coli (EIEC) [20, 25, 34].
In our study, primers were designed based on the prevalent species responsible for the majority of shigellosis cases [2, 4, 6, 7]. Four highly specific genes (invC, rfc, wbgZ, and rfpB) that can best detect Shigella at the genus and species level were identified. Because invC is present among all of the Shigella spp., rfc, wbgZ, and rfpB were combined with invC for speciation of the Shigella strains. The primer for S. flexneri that targets the rfc gene was designed based on Houng et al. , and it allows discrimination between Shigella and EIEC in faecal samples. Similarly, the three other highly specific primers were designed based on the homologous sequences retrieved from GenBank (NCBI). S. boydii species identification was not included in this study because of its low prevalence in developing and industrialized countries. However, the presence of the invC band specific for Shigella genus and the absence of all other amplicons specific for Shigella spp. can be considered to be the detection criteria for S. boydii.
Following the successful application of the primers individually, they were mixed to produce the pentaplex PCR. The mixing of primers in a single tube decreases costs and time and increases the ease of the assay. Although numerous reports of PCR assays for the detection of Shigella spp. exist [18, 20, 25, 34], only a few of them have incorporated internal controls to rule out false negatives . According to guidelines for Molecular Diagnostic Methods for Infectious Diseases (MM3-A2), incorporation of an internal control in the reaction is essential for the diagnostic test to exclude false negative result or the presence of inhibitors. In the present study, inclusion of a 1319 bp internal control in the pentaplex PCR assay helped us to rule out false negatives or PCR inhibitors. The primers were designed with great care; BLAST and alignment results of the sequence confirmed that it did not cross-react with closely related species such as enteroinvasive Escherichia coli (EIEC) which gives rise to similar illness as shigellosis. However, it was unfortunate that EIEC strain was not available to be tested in this study.
The pentaplex PCR developed in our study successfully amplified all five amplicons from a single reaction tube, and the primers did not interact with each other to produce false negatives. Compatibility of primers with target amplicons was confirmed by sequencing the PCR products derived from the five representative strains. The pentaplex mixture was tested with 120 clinical strains and also against other Gram positive and Gram negative strains to determine the primers’ specificity. The primers were found to be highly specific in identifying Shigella spp. However, in some cases nonspecific amplicon was weak and fell outside the expected size range for the primers applied and therefore was of no concern. These nonspecific amplifications are likely due to low levels of nonspecific binding between the primers and the bacterial genomic DNA.
The presence of PCR inhibitors in stool samples (e.g., bilirubin, bile salts, and heme in the faeces) may inhibit amplification and limit the usefulness of PCR technique [36, 37]. As reported by Theron et al.  and Thong et al. , an enrichment procedure prior to PCR enhances the total number of bacteria present, which helps to dilute the PCR inhibitory substances. As stated by the manufacturer of Gram negative broth (GNB), citrate and deoxycholate in the broth act as selective agents and suppress the growth of Gram positive organisms, including some coliform bacteria. The additional step of preincubating spiked faecal sample in GNB helps to eliminate the natural inhibitors and could enhance the viability of Shigella spp. in samples [29, 38]. A preliminary study with clinical specimens showed no cross reaction with other non-Shigella strains, however, to check the real performance of the developed test, a larger positive sample size need to be further investigated. The 4 h enrichment step would increase the total number of bacteria present and enhance the sensitivity of the assay. The sensitivity level achieved in our study was comparable to that of other studies. For example, Houng et al.  detected up to 7.4 × 104 CFU/mL of Shigella by amplifying IS 630 sequences, Yavzori et al.  detected at 104 CFU of Shigella per gram of faeces with the use of virF primers, and Thong et al.  reported a detection level of 5.0 × 104 CFU/mL of Shigella by amplifying ial and ipaH sequences in Shigella spp. Thus, the average detection of pentaplex PCR described in this study (5.4 × 104 CFU/mL) is within the common detection limit for Shigella.
In conclusion, the pentaplex PCR assay developed in this study was able to detect four genes that are essential for the detection and differentiation of Shigella at the genus and species levels simultaneously in a single test within 4 h. The built-in internal control in this assay prevented false negative results. The pentaplex PCR assay was highly sensitive and could provide results on the same day that a specimen was submitted for evaluation, which is critical during outbreaks.
Conflict of Interests
The authors declare that they have no conflict of interests.
This study was supported by Research University Cluster Grant entitled “Molecular approaches to fundamental studies on biomarkers and development of sustainable rapid nanobiodiagnostics to enteric diseases for low resource settings” (2011–2013). We gratefully acknowledge Institute for Postgraduate Studies, Universiti Sains Malaysia, for providing the fellowship assistance and the Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, for providing facilities and isolates.
- M. L. Bennish and B. J. Wojtyniak, “Mortality due to shigellosis: community and hospital data,” Reviews of Infectious Diseases, vol. 13, supplement 4, pp. S245–S251, 1991.
- S. K. Niyogi, “Shigellosis,” Journal of Microbiology, vol. 43, no. 2, pp. 133–143, 2005.
- A. Hiranrattana, J. Mekmullica, T. Chatsuwan, C. Pancharoen, and U. Thisyakorn, “Childhood shigellosis at King Chulalongkorn Memorial Hospital, Bangkok, Thailand: a 5-year review (1996–2000),” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 36, no. 3, pp. 683–685, 2005.
- S. M. Faruque, R. Khan, M. Kamruzzaman et al., “Isolation of Shigella dysenteriae type 1 and S. flexneri strains from surface waters in Bangladesh: comparative molecular analysis of environmental Shigella isolates versus clinical strains,” Applied and Environmental Microbiology, vol. 68, no. 8, pp. 3908–3913, 2002.
- K. K. B. Singh, S. C. Ojha, Z. Z. Deris, and R. A. Rahman, “A 9-year study of shigellosis in Northeast Malaysia: antimicrobial susceptibility and shifting species dominance,” Journal of Public Health, vol. 19, no. 3, pp. 231–236, 2011.
- B. A. Oyofo, M. Lesmana, D. Subekti et al., “Surveillance of bacterial pathogens of diarrhea disease in Indonesia,” Diagnostic Microbiology and Infectious Disease, vol. 44, no. 3, pp. 227–234, 2002.
- D. Sur, T. Ramamurthy, J. Deen, and S. K. Bhattacharya, “Shigellosis: challenges & management issues,” The Indian Journal of Medical Research, vol. 120, no. 5, pp. 454–462, 2004.
- S. Ashkenazi, “Shigella infections in children: new insights,” Seminars in Pediatric Infectious Diseases, vol. 15, no. 4, pp. 246–252, 2004.
- V. L. Kodati, S. Govindan, S. Movva, S. Ponnala, and Q. Hasan, “Role of Shigella infection in endometriosis: a novel hypothesis,” Medical Hypotheses, vol. 70, no. 2, pp. 239–243, 2008.
- B. R. Warren, M. E. Parish, and K. R. Schneider, “Shigella as a foodborne pathogen and current methods for detection in food,” Critical Reviews in Food Science and Nutrition, vol. 46, no. 7, pp. 551–567, 2006.
- World Health Organization, “Initiative for Vaccine Research (IVR),” in Diarrhoeal Diseases, Shigellosis, 2009, http://www.who.int/vaccine_research/diseases/diarrhoeal/en/index6.html.
- P. O. Ozuah and H. Adam, “Shigella update,” Pediatrics in Review, vol. 19, no. 3, p. 100, 1998.
- P. Shears, “Shigella infections,” Annals of Tropical Medicine and Parasitology, vol. 90, no. 2, pp. 105–114, 1996.
- B. Edwards, “Salmonella and Shigella species,” Clinics in Laboratory Medicine, vol. 19, no. 3, pp. 469–487, 1999.
- K. Khalil, S. R. Khan, K. Mazhar, B. Kaijser, and G. B. Lindblom, “Occurrence and susceptibility to antibiotics of Shigella species in stools of hospitalized children with bloody diarrhea in Pakistan,” The American Journal of Tropical Medicine and Hygiene, vol. 58, no. 6, pp. 800–803, 1998.
- S. Dutta, A. Chatterjee, P. Dutta et al., “Sensitivity and performance characteristics of a direct PCR with stool samples in comparison to conventional techniques for diagnosis of Shigella and enteroinvasive Escherichia coli infection in children with acute diarrhoea in Calcutta, India,” Journal of Medical Microbiology, vol. 50, no. 8, pp. 667–674, 2001.
- M. S. Islam, M. S. Hossain, M. K. Hasan et al., “Detection of Shigellae from stools of dysentery patients by culture and polymerase chain reaction techniques,” Journal of Diarrhoeal Diseases Research, vol. 16, no. 4, pp. 248–251, 1998.
- H. S. H. Houng, O. Sethabutr, and P. Echeverria, “A simple polymerase chain reaction technique to detect and differentiate Shigella and enteroinvasive Escherichia coli in human feces,” Diagnostic Microbiology and Infectious Disease, vol. 28, no. 1, pp. 19–25, 1997.
- E. Villalobo and A. Torres, “PCR for detection of Shigella spp. in mayonnaise,” Applied and Environmental Microbiology, vol. 64, no. 4, pp. 1242–1245, 1998.
- K. L. Thong, S. L. L. Hoe, S. D. Puthucheary, and R. M. Yasin, “Detection of virulence genes in Malaysian Shigella species by multiplex PCR assay,” BMC Infectious Diseases, vol. 5, no. 8, pp. 1–7, 2005.
- GenBank, http://www.ncbi.nlm.nih.gov/.
- GeneDoc, http://www.nrbsc.org/downloads/.
- Molecular Diagnostic Methods for Infectious Diseases, Approved Guideline (CLSI MM3-A2), vol. 26, 2nd edition, 2006.
- R. Schuch and A. T. Maurelli, “Virulence plasmid instability in Shigella flexneri 2a is induced by virulence gene expression,” Infection and Immunity, vol. 65, no. 9, pp. 3686–3692, 1997.
- K. R. S. Aranda, U. Fagundes-Neto, and I. C. A. Scaletsky, “Evaluation of multiplex PCRs for diagnosis of infection with diarrheagenic Escherichia coli and Shigella spp,” Journal of Clinical Microbiology, vol. 42, no. 12, pp. 5849–5853, 2004.
- W. Luo, S. Wang, and X. Peng, “Identification of shiga toxin-producing bacteria by a new immuno-capture toxin gene PCR,” FEMS Microbiology Letters, vol. 216, no. 1, pp. 39–42, 2002.
- V. D. Thiem, O. Sethabutr, L. von Seidlein et al., “Detection of Shigella by a PCR assay targeting the ipaH gene suggests increased prevalence of shigellosis in Nha Trang, Vietnam,” Journal of Clinical Microbiology, vol. 42, no. 5, pp. 2031–2035, 2004.
- X. Peng, W. Luo, J. Zhang, S. Wang, and S. Lin, “Rapid detection of Shigella species in environmental sewage by an immunocapture PCR with universal primers,” Applied and Environmental Microbiology, vol. 68, no. 5, pp. 2580–2583, 2002.
- J. Theron, D. Morar, M. Du Preez, V. S. Brözel, and S. N. Venter, “A sensitive seminested PCR method for the detection of Shigella in spiked environmental water samples,” Water Research, vol. 35, no. 4, pp. 869–874, 2001.
- M. P. Jackson, “Detection of shiga toxin-producing Shigella dysenteriae type 1 and Escherichia coli by using polymerase chain reaction with incorporation of digoxigenin-11-dUTP,” Journal of Clinical Microbiology, vol. 29, no. 9, pp. 1910–1914, 1991.
- C. I. B. Kingombe, M. L. Cerqueira-Campos, and J. M. Farber, “Molecular strategies for the detection, identification, and differentiation between enteroinvasive Escherichia coli and Shigella spp,” Journal of Food Protection, vol. 68, no. 2, pp. 239–245, 2005.
- O. Sethabutr, M. Venkatesan, S. Yam et al., “Detection of PCR products of the ipaH gene from Shigella and enteroinvasive Escherichia coli by enzyme linked immunosorbent assay,” Diagnostic Microbiology and Infectious Disease, vol. 37, no. 1, pp. 11–16, 2000.
- D. R. Call, “Challenges and opportunities for pathogen detection using DNA microarrays,” Critical Reviews in Microbiology, vol. 31, no. 2, pp. 91–99, 2005.
- M. J. Farfán, T. A. Garay, C. A. Prado, I. Filliol, M. T. Ulloa, and C. S. Toro, “A new multiplex PCR for differential identification of Shigella flexneri and Shigella sonnei and detection of Shigella virulence determinants,” Epidemiology and Infection, vol. 138, no. 4, pp. 525–533, 2010.
- O. G. Gómez-Duarte, J. Bai, and E. Newell, “Detection of Escherichia coli, Salmonella spp., Shigella spp., Yersinia enterocolitica, Vibrio cholerae, and Campylobacter spp. enteropathogens by 3-reaction multiplex polymerase chain reaction,” Diagnostic Microbiology and Infectious Disease, vol. 63, no. 1, pp. 1–9, 2009.
- L. Rossen, P. Nørskov, K. Holmstrøm, and O. Rasmussen, “Inhibition of PCR by components of food samples, microbial diagnostic assays and DNA-extraction solutions,” International Journal of Food Microbiology, vol. 17, no. 1, pp. 37–45, 1992.
- I. Wilson, “Inhibition and facilitation of nucleic acid amplification,” Applied and Environmental Microbiology, vol. 63, no. 10, pp. 3741–3751, 1997.
- W. I. Taylor and D. Schelhart, “Effect of temperature on transport and plating media for enteric pathogens,” Journal of Clinical Microbiology, vol. 2, no. 4, pp. 281–286, 1975.
- M. Yavzori, D. Cohen, R. Wasserlauf, R. Ambar, G. Rechavi, and S. Ashkenazi, “Identification of Shigella species in stool specimens by DNA amplification of different loci of the Shigella virulence plasmid,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 13, no. 3, pp. 232–237, 1994.
Copyright © 2013 Suvash Chandra Ojha et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.